You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》三葉草生物(02197.HK)近上限定價13.38元 公開發售超購3.4倍
生物技術公司三葉草生物(02197.HK)公佈招股結果,每股發售價定爲13.38元,爲招股價12.8至13.5元的接近上限定價,香港公開發售部分錄得超額認購約3.4倍,每手500股計,一手中籤率爲35%,要認購3手即1,500股纔可穩獲一手。 該股將於明日(5日)掛牌。聯席保薦人、聯席全球協調人、聯席賬簿管理人及聯席牽頭經辦人爲高盛及中金公司,聯席全球協調人、聯席賬簿管理人及聯席牽頭經辦人爲高盛、中金公司及瑞信。 基石投資者合共認購約8,052.55萬股,佔緊隨全球發售完成後公司已發行股本約7%,當中OrbiMed認購1,453.55萬股,HHLR認購1,279.1萬股,淡馬錫認購1,162.85萬股。 公司料是次上市淨集約18.7億元,當中約65%用於核心產品及相關產品的研發、生產及商業化;約22.5%用於管線中其他產品的研發、生產及商業化;約12.5%用作營運資金及其他一般公司用途。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account